A
ABCL
Abcellera Biologics Inc.
3.860
+0.100+2.66%Pre Market: 3.920 +0.060 +1.55%04:39 04/16 EDT
OPEN/PREV CLOSE3.770/3.760
TODAY RANGE3.770-3.900
VOL7.79K
MARKET CAP1.17B
52 WEEK RANGE1.940-6.52
AVG VOL (3M)3.54M
% TURNOVER0.99%
TURNOVER0
P/E (TTM)-7.8743
% RANGE3.46%
EPS(TTM)-0.4902
P/E(FORWARD)-5.2877
P/B1.200
BVPS3.217
DIVIDEND--
P/S15.45
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP903.81M
SHARES OUTSTANDING303.16M
NEXT EARNINGS05/06-05/11
FREE FLOAT234.15M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
How Investors Are Reacting To AbCellera Biologics (ABCL) After New Jones Trading Coverage Initiation
Simply Wall St·5d ago
A Look At AbCellera Biologics (ABCL) Valuation After New Optimistic Coverage From Jones Trading
Dow Jones·5d ago
AbCellera Biologics Initiated at Buy by Jones Trading
TipRanks·6d ago
AbCellera initiated with a Buy at JonesResearch
TipRanks·04/06 11:35
AbCellera Biologics (ABCL) Receives a Buy from Truist Financial
Simply Wall St·04/03 19:21
Is AbCellera (ABCL) Quietly Rewriting Its Investment Story With Cash Reserves And Advancing Trials?
Seeking Alpha·03/26 10:08
AbCellera: Dart-Board Approach Reflects Trading Premium (Upgrade)
Seeking Alpha·03/18 00:54
Tracking Baker Brothers Portfolio - Q4 2025 Update
Simply Wall St·03/10 09:17
A Look At AbCellera Biologics (ABCL) Valuation After Annual Earnings Reveal Higher Revenue And A Narrower Net Loss
TipRanks·03/03 02:07
Major Investor Quietly Ramps Up Stake in AbCellera Biologics
Same Industry
Name/Symbol
Change%
Price